The global Medical Aesthetics Market was valued at USD 8.00 billion in 2016 and is projected to reach USD 19.57 billion by 2025, growing at a CAGR of 10.45% from 2017 to 2025.
The global market covers a large variety of daily as well as non-daily use based products. The market is increasingly expanding because of simultaneous increase in the demand as well consumption of the products, coupled with popularity of techniques like liposuction and beauty wellness surgeries and products all over the globe.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing applications and demand of minimally invasive medical aesthetics
1.2 Growing Geriatric population
1.3 Growing awareness amongst customers
1.4 Technological Advancements
1.5 Human physiology friendly aesthetic devices and demand in population
2. Market Restraints
2.1 Lack of systematic regulations
2.2 Limited focus on dermatological products by market players
Market Segmentation:
1. Global Medical Aesthetics Market, by End User:
1.1 Clinics and Medical Spas
1.2 Beauty Centers
2. Global Medical Aesthetics Market, by Product:
2.1 Physician-Dispensed Cosmeceuticals and Skin Lighteners
2.2 Laser Resurfacing Devices
2.3 Physician-Dispensed Eyelash Products
2.4 Laser Hair Removal Devices
2.5 Tattoo Removal Devices
2.6 Thread Lift Products
2.7 Breast Implants
2.7.1 Silicone Breast Implants
2.7.2 Saline Breast Implants
2.7.3 Cohesive Semisolid Gel Breast Implants
2.8 Facial Aesthetic
2.8.1 Dermal Fillers
2.8.2 Botulinum Toxin
2.8.3 Microdermabrasion
2.8.4 Chemical Peels
2.9 Energy-Based Devices
2.9.1 Nonsurgical Fat Reduction Devices
2.9.2 Nonsurgical Skin Tightening Devices
2.9.3 Cellulite Reduction Devices
2.9.4 Liposuction Devices
3. Global Medical Aesthetics Market, by Region:
3.1 North America (U.S., Canada, Mexico)
3.2 Europe (Germany, UK, France, Rest of Europe)
3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
3.4 Latin America (Brazil, Argentina, Rest of Latin America)
3.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Allergan, PLC (A Division of Actavis PLC)
2. Solta Medical, Inc. (A Division of Valeant Pharmaceuticals International, Inc.)
3. Syneron Medical Ltd.
4. Photomedex, Inc.
5. Cynosure, Inc.
6. Lumenis Ltd.
7. Johnson & Johnson
8. Zeltiq Aesthetics, Inc.
9. Merz Aesthetics, Inc. (A Division of Merz Pharma GmbH & Co. KGaA)
10. Galderma S.A. (A Subsidiary of Nestlé S.A.)
11. Alma Lasers, Ltd. (Acquired By Shanghai Fosun Pharmaceutical (Group) Co., Ltd.)
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Medical Aesthetics Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL MEDICAL AESTHETICS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL MEDICAL AESTHETICS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL MEDICAL AESTHETICS MARKET, BY END USER
5.1 Overview
5.2 Clinics and Medical Spas
5.3 Beauty Centers
6 GLOBAL MEDICAL AESTHETICS MARKET, BY PRODUCT
6.1 Overview
6.2 Physician-Dispensed Cosmeceuticals and Skin Lighteners
6.3 Laser Resurfacing Devices
6.4 Physician-Dispensed Eyelash Products
6.5 Laser Hair Removal Devices
6.6 Tattoo Removal Devices
6.7 Thread Lift Products
6.8 Breast Implants
6.8.1 Silicone Breast Implants
6.8.2 Saline Breast Implants
6.8.3 Cohesive Semisolid Gel Breast Implants
6.9 Facial Aesthetic
6.9.1 Dermal Fillers
6.9.2 Botulinum Toxin
6.9.3 Microdermabrasion
6.9.4 Chemical Peels
6.10 Energy-Based Devices
6.10.1 Nonsurgical Fat Reduction Devices
6.10.2 Nonsurgical Skin Tightening Devices
6.10.3 Cellulite Reduction Devices
6.10.4 Liposuction Devices
7 GLOBAL MEDICAL AESTHETICS MARKET, BY GEOGRAPHY
7.1 Overview
7.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
7.5.1 Brazil
7.5.2 Argentina
7.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
8 GLOBAL MEDICAL AESTHETICS MARKETCOMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Share
8.3 Vendor Landscape
8.4 Key Development Strategies
9 COMPANY PROFILES
9.1 Allergan, PLC
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 Solta Medical, Inc.
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Syneron Medical Ltd.
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Photomedex, Inc.
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 Cynosure, Inc.
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Lumenis Ltd.
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 Johnson & Johnson
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 Zeltiq Aesthetics, Inc.
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 Merz Aesthetics, Inc.
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Developments
9.10 Galderma S.A.
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Developments
9.11 Alma Lasers, Ltd.
9.11.1 Overview
9.11.2 Financial Performance
9.11.3 Product Outlook
9.11.4 Key Developments
10 Appendix
10.1 Related Reports